Europe is the most profitable area, accounting for around 30% of the worldwide mesotherapy business. Factors boosting the mesotherapy market in the area include an increasing middle-aged population, an improved reimbursement environment, increased product awareness, and the availability of high-end commercialised mesotherapy products. The bulk of mesotherapy product producers are based in Europe, and they are experiencing significant changes in order to expand their geographical reach around the globe. Increased R&D activities, collaborative efforts, and rising demand for new goods will propel the European market forward over the projection period.
Mesotherapy is not FDA authorised in the United States, but because the majority of dermatologists and cosmetic experts are willing to use Mesotherapy products, the United States provides a considerable revenue generating opportunity throughout the projection period. On the other hand, the coronavirus (COVID-19) epidemic is sweeping across continents, wreaking havoc on the humanitarian and economic systems. The virus started in Wuhan, China, and has since spread throughout North America and Europe. Governments in Italy, Spain, and France have enforced statewide lockdowns and self-quarantine rules in response to the exponential surge of COVID-19 caseloads. Furthermore, the coronavirus's survival time varies with surface.
Read the report- https://cmi-latestreportorientedblogs.blogspot.com/2022/07/mesotherapy-market-growth-analysis.html
